The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 778K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

21 articles for DJ Maly


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
28
5-Aminopyrazole-4-carboxamide analogues are selective inhibitors of Plasmodium falciparum microgametocyte exflagellation and potential malaria transmission blocking agents.EBI
University of Washington
36
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1.EBI
University of Washington
35
Potent and selective inhibitors of CDPK1 fromEBI
University of Washington
74
Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity.EBI
University of Washington
39
Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1.EBI
University of Washington
16
Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1.EBI
University of Washington
49
Discovery of Potent and Selective Inhibitors of Calcium-Dependent Protein Kinase 1 (CDPK1) from C. parvum and T. gondii.EBI
University of Washington
13
Biochemical and pharmacological profiling of the pro-survival protein Bcl-xL.EBI
University of Washington
5
Tyrosylprotein sulfotransferase inhibitors generated by combinatorial target-guided ligand assembly.EBI
University Of California
34
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.EBI
University of Washington
4
ACC inhibitor and use thereofBDB
Nanjing Ruijie Pharma
3
USE OF PRIDOPIDINE AND ANALOGS FOR THE TREATMENT OF ANXIETY AND DEPRESSIONBDB
Prilenia Neurotherapeutics
2
5-HT2A agonists for use in treatment of depressionBDB
Lophora
78
Fused pyrimidine compound or salt thereofBDB
Taiho Pharmaceutical
262
Heteroaryl substituted aminopyridine compoundsBDB
Bristol Myers Squibb
6
Sulfamide and sulfamate inhibitors of hHint1BDB
University of Minnesota
21
1-sulfonamido-4-aryloxy compounds, and preparation method and medicinal application thereofBDB
China Pharmaceutical University
2
D3 dopamine receptor agonists to treat dyskinesia in parkinson's diseaseBDB
Drexel University
26
Novel trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines as mu opioid receptor antagonists with improved opioid receptor selectivity profiles.BDB
Adolor
8
Discovery of a potent, selective, and orally bioavailable c-Met inhibitor: 1-(2-hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (AMG 458).BDB
Amgen